690 related articles for article (PubMed ID: 24388217)
1. Immunopathogenesis of neuromyelitis optica.
Levy M; Wildemann B; Jarius S; Orellano B; Sasidharan S; Weber MS; Stuve O
Adv Immunol; 2014; 121():213-42. PubMed ID: 24388217
[TBL] [Abstract][Full Text] [Related]
2. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
4. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
5. Optic neuritis in neuromyelitis optica.
Levin MH; Bennett JL; Verkman AS
Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
[TBL] [Abstract][Full Text] [Related]
7. [Neuromyelitis optica: a clinical update].
Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
Drori T; Chapman J
Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of neuromyelitis optica.
Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
[TBL] [Abstract][Full Text] [Related]
11. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S
Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica: clinical features, immunopathogenesis and treatment.
Jarius S; Wildemann B; Paul F
Clin Exp Immunol; 2014 May; 176(2):149-64. PubMed ID: 24666204
[TBL] [Abstract][Full Text] [Related]
13. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
Jordan B; Eger K; Kornhuber ME; Zierz S
Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
[TBL] [Abstract][Full Text] [Related]
14. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
Saikali P; Cayrol R; Vincent T
Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica pathogenesis and aquaporin 4.
Graber DJ; Levy M; Kerr D; Wade WF
J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
[TBL] [Abstract][Full Text] [Related]
16. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M
Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985
[TBL] [Abstract][Full Text] [Related]
17. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
[TBL] [Abstract][Full Text] [Related]
19. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).
Asgari N; Owens T; Frøkiaer J; Stenager E; Lillevang ST; Kyvik KO
Acta Neurol Scand; 2011 Jun; 123(6):369-84. PubMed ID: 20880299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]